Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management

Overview of attention for article published in Frontiers in immunology, May 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 52 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 41,405 followers.

Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, ... https://t.co/iSMxCIoSfc

28 Nov 2021

Reply Repost Favourite

بلا شك جهود العلماء في ايجاد حلول مناعيه ضد أحد اخطر الامراض مراوغه 'Cancer' مستمره حيث انه تم اختبار هذا النهج ' Chekpoint Inhibitors ' ع ١٢ مريض بسرطان الرئه ! النتائج كانت مطمنه والعلاج كان فعلا بشكل جيد وآمن الى حد للاطلاع : https://t.co/OYOgoYp1A3

16 Aug 2021

Reply Repost Favourite

Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, ... https://t.co/iSMxCIoSfc

22 Jun 2021

Reply Repost Favourite

Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management https://t.co/GvG2v8jbMy https://t.co/laPxb8nct9

14 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.